Blog
944 Articles
Not Just a Survivor . . . A Sur-thriver!
Jon Oelke found that he has a rare genetic mutation, which gives him a back-up plan for treatment if his initial chemo stops working.
Molecular Testing for Pancreatic Cysts: The Doctor’s View
Dr. Aatur Singhi outlines how testing pancreatic cyst fluid can help determine a patient’s risk of getting pancreatic cancer.
Stand Up, Speak Out
Dr. Elizabeth Jaffee outlines all the ways YOU can stand up for research and speak out to make sure funding for science is not cut further.
The Latest Research from the 2025 AACR Special Conference
Highlights from the 2025 AACR Special Conference on pancreatic cancer research include updates on drugs that work on KRAS, AI and early detection, and biomarkers.
Attitude and Effort
Long-term survivor Ken Brown was determined to beat pancreatic cancer, even trying the new-at-the-time protocol of chemo before surgery.
Integrative Oncology Made Easy
Terri Crudup is part of a team of cancer survivors and advocates for integrative oncology that helped put together a free eBook for patients.
From Pancreatic Cancer to Blessed
After recovering from chemotherapy and a Whipple procedure, Linda Burchett knows she is blessed to be able to travel and enjoy life as a long-term survivor.
Novel Oral Drug Shows Promise
Dr. Barbara Ma provides context for the nine-month data on a clinical trial of the novel drug atebimetinib and standard chemo.
Study Finds Rare Immunotherapy Exceptional Responders
Immunotherapy is not very effective against pancreatic cancer, but Dr. Jordan Winter is taking a closer look at patients who benefitted to see what’s different about them.
Don’t Let This Happen to You
Long-term survivor Andy Lyons took his brother’s words to heart and went into a monitoring program for pancreatic cancer.
36 Years and Counting
When Donna Caparida had severe pain in her side, doctors found pancreatic cancer. Thirty-six years later she’s a long-term survivor.
PASS-01 Trial Results: Filling the Gaps in Personalized Medicine
The PASS-01 trial results provide data to help clarify how the subtypes of pancreatic cancer respond to the two main treatment protocols.
PLATINUM Clinical Trial Actively Recruiting
The PLATINUM clinical trial, for patients with BRCA and PALB2 mutations, seeks participants. Dr. Andrew Ko outlines the trial.
Fleeting, Fragile, and Funny
Eric Egelman had molecular profiling of his tumor and a KRAS mutation was found. This qualified him for a vaccine clinical trial.
Six Important Points
Russell Reed learned to advocate for himself and shares six important points that he learned on his treatment journey.